Acitretin Loaded Nanocarrier Gel: Formulation and Exploration of In-vitro Release Kinetics

Author(s): Anupriya Kapoor*, Nikunj sethi, Navneet Verma

Journal Name: Current Nanomedicine
(Formerly Recent Patents on Nanomedicine)

Volume 11 , Issue 2 , 2021


Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Abstract:

Background: The present study intended to design and evaluate Acitretin (ACT) loaded Nanostructured Lipid Carriers (NLCs) for the management of psoriasis through topical application. Psoriasis is an autoimmune disorder that affects the skin and is characterized by irritation, red flaky patches over different parts of the body. ACT is an analog of vitamin A that is used for the management of psoriasis via the oral route. The prime demerit associated with oral route delivery of a drug is the teratogenic effect associated with the active molecule and side effects like dry mouth, runny nose, hair loss, taste changes, chapped lips, etc. that are the major contributing factors of reduced patient compliance.

Objective: The objective of the present research work was to develop a topical formulation of ACT. Developing topical formulation for the same can result in enhanced patient compliance and can be worth compared to the marketed oral formulation of the drug.

Methods: ACT loaded NLCs were prepared by hot homogenization method using oleic acid as a liquid lipid and stearic acid as a solid lipid in a 7:3 ratio along with the combination of a non-ionic surfactant (Tween 80) and an anionic surfactant (sodium lauryl sulphate).

Results: In several optimization experiments, formulation F3 was found to be most appropriate for formulating gel. Morphological information obtained from SEM reinforced the formation of particles with nearly spherical morphology. The optimized formulation had a mean diameter of 363 nm, as founded by Zetasizer. XRD studies affirmed that the formulation exhibits amorphous nature, which is an essential character of NLC. An optimized formulation was further incorporated in the gel by using Carbopol 940P as a gelling agent. In vitro release studies indicated 96.85 ± 2% release in 8 hours with Korsmeyer- Peppas model release kinetics. The observed n value1.391 for drug release for F3G2 bespeak Super case II transport may be the result of sorption of the drug from the surface of NLC that is controlled by stress-induced relaxation which occurs at the boundary of the swollen shell.

Conclusion: In vitro characterization of ACT (Acitretin) loaded NLC supports the objective that NLC can serve as a potential carrier for topical delivery of ACT and can also reduce oral toxicity associated with drug after stringent evaluation in the near future.

Keywords: NLC, hot homogenization, release kinetics, korsmeyer-peppas, nanocarrier gel, acitretin.

[1]
Freitas C, Müller RH. Correlation between long-term stability of solid lipid nanoparticles (SLN)and crystallinity of the lipid phase. Eur J Pharm Biopharm 1999; 47(2): 125-32.
[http://dx.doi.org/10.1016/S0939-6411(98)00074-5] [PMID: 10234536]
[2]
Battaglia L, Gallarate M. Lipid nanoparticles: State of the art, new preparation methods and challenges in drug delivery. Expert Opin Drug Deliv 2012; 9(5): 497-508.
[http://dx.doi.org/10.1517/17425247.2012.673278] [PMID: 22439808]
[3]
Singh AV, Maharjan RS, Kanase A, et al. Machine-learning-based approach to decode the influence of nanomaterial properties on their interaction with cells. ACS Appl Mater Interfaces 2021; 13(1): 1943-55.
[http://dx.doi.org/10.1021/acsami.0c18470] [PMID: 33373205]
[4]
Pandey AT, Pandey I, Hachenberger Y, et al. Emerging paradigm against global antimicrobial resistance via bioprospecting of mushroom into novel nanotherapeutics development. Trends Food Sci Technol 2020; 106: 333-4.
[http://dx.doi.org/10.1016/j.tifs.2020.10.025]
[5]
Christophers E. Psoriasis-epidemiology and clinical spectrum. Clin Exp Dermatol 2001; 26(4): 314-20.
[http://dx.doi.org/10.1046/j.1365-2230.2001.00832.x] [PMID: 11422182]
[6]
Palfreeman AC, McNamee KE, McCann FE. New developments in the management of psoriasis and psoriatic arthritis: A focus on apremilast. Drug Des Devel Ther 2013; 7: 201-10.
[http://dx.doi.org/10.2147/DDDT.S32713] [PMID: 23569359]
[7]
Conrad C, Gilliet M. Psoriasis: From pathogenesis to targeted therapies. Clin Rev Allergy Immunol 2018; 54(1): 102-13.
[http://dx.doi.org/10.1007/s12016-018-8668-1] [PMID: 29349534]
[8]
Dong J, Goldenberg G. New biologics in psoriasis: An update on IL-23 and IL-17 inhibitors. Cutis 2017; 99(2): 123-7.
[PMID: 28319618]
[9]
Fotiadou C, Lazaridou E, Sotiriou E, Ioannides D. Targeting IL-23 in psoriasis: Current perspectives. Psoriasis (Auckl) 2018; 8: 1-5.
[http://dx.doi.org/10.2147/PTT.S98893] [PMID: 29441315]
[10]
Blauvelt A, Reich K, Warren RB, et al. Secukinumab re-initiation achieves regain of high response levels in patients who interrupt treatment for moderate to severe plaque psoriasis. Br J Dermatol 2017; 177(3): 879-81.
[http://dx.doi.org/10.1111/bjd.15656] [PMID: 28498514]
[11]
Khemis A, Cavalié M, Montaudié H, Lacour JP, Passeron T. Rebound pustular psoriasis after brodalumab discontinuation. Br J Dermatol 2016; 175(5): 1065-6.
[http://dx.doi.org/10.1111/bjd.14627] [PMID: 27037661]
[12]
Lammer EJ, Chen DT, Hoar RM, et al. Retinoic acid embryopathy. N Engl J Med 1985; 313(14): 837-41.
[http://dx.doi.org/10.1056/NEJM198510033131401] [PMID: 3162101]
[13]
Geiger J-M, Baudin M, Saurat J-H. Teratogenic risk with etretinate and acitretin treatment. Dermatology 1994; 189(2): 109-16.
[http://dx.doi.org/10.1159/000246811] [PMID: 8075435]
[14]
Gaba B, Fazil M, Khan S, Ali A, Baboota S, Ali J. Nanostructured lipid carrier system for topical delivery of terbinafine hydrochloride. Bull Fac Pharm Cairo Univ 2015; 53(2): 147-59.
[http://dx.doi.org/10.1016/j.bfopcu.2015.10.001]
[15]
Jain P, Rahi P, Pandey V, Asati S, Soni V. Nanostructure lipid carriers: A modish contrivance to overcome the ultraviolet effects. Egypt J Basic Appl Sci 2017; 4(2): 89-100.
[http://dx.doi.org/10.1016/j.ejbas.2017.02.001]
[16]
Jessy S, Sharvari G. Transethosomes and ethosomes for enhanced transdermal delivery of ketorolac tromethamine. Int J Curr Pharm Res 2014; 6(4): 88-93.
[17]
Dwivedi C, Pandey H, Pandey AC, et al. In vivo Biocompatibility of electrospun biodegradable dual carrier (Antibiotic + Growth Factor) in a mouse model-implications for rapid wound healing. Pharmaceutics 2019; 11(4): 180.
[http://dx.doi.org/10.3390/pharmaceutics11040180] [PMID: 31013995]
[18]
Mozafari MR, Mazaheri E, Dormiani K. Simple equations pertaining to the particle number and surface area of metallic, polymeric, lipidic and vesicular nanocarriers. Sci Pharm 2021; 89: 2-15.
[http://dx.doi.org/10.3390/scipharm89020015]
[19]
Mei X, Kenneth A, Gabriella B, Mei X. Formulation and evaluation of antibacterial creams and gels containing metal ions for topical application. J Pharm (Cairo) 2016; 1-10.
[20]
Thorat SP, Rane SI. In vitro evaluation of lecithin (soy and egg) based aceclofenac organogels. J Pharm Res 2010; 3(6): 1438-41.
[21]
Badmaev V, Majeed M, Prakash L. Piperine derived from black pepper increases the plasma levels of coenzyme Q10 following oral supplementation. J Nutr Biochem 2000; 11(2): 109-13.
[http://dx.doi.org/10.1016/S0955-2863(99)00074-1] [PMID: 10715596]
[22]
Bharadwaj S, Gupta GD, Sharma VK. Topical gel: A novel approach for drug delivery. J Chem Biol Phys Sci 2012; 2(2): 856-67.
[23]
Nayak SH, Nakhat PD, Yeole PG. Development and evaluation of cosmeceutical hair styling gels of ketoconazole. Indian J Pharm Sci 2005; 52: 231-3.
[24]
Ubaid M, Ilyas S, Mir S, et al. In vitro formulation and evaluation of carbopol 934-based modified clotrimazole gel for topical application. An Acad Bras Cienc 2016; 88(4): 2303-17.
[http://dx.doi.org/10.1590/0001-3765201620160162] [PMID: 27925034]
[25]
Ahmed OAA, Badr-eldin SM, Ahmed TA. In vitro kinetic study of the release and stability of Theophylline floating beads. Int J Pharm Pharm Sci 2013; 5: 1-6.
[26]
Kovacevic A, Savic S, Vuleta G, Müller RH, Keck CM. Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): Effects on size, physical stability and particle matrix structure. Int J Pharm 2011; 406(1-2): 163-72.
[http://dx.doi.org/10.1016/j.ijpharm.2010.12.036] [PMID: 21219990]
[27]
Coors EA, Seybold H, Merk HF, Mahler V. Polysorbate 80 in medical products and nonimmunologic anaphylactoid reactions. Ann Allergy Asthma Immunol 2005; 95(6): 593-9.
[http://dx.doi.org/10.1016/S1081-1206(10)61024-1] [PMID: 16400901]
[28]
Eastoe J, Dalton JS. Dynamic surface tension and adsorption mechanisms of surfactants at the air-water interface. Adv Colloid Interface Sci 2000; 85(2-3): 103-44.
[http://dx.doi.org/10.1016/S0001-8686(99)00017-2] [PMID: 10768479]
[29]
Müller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 2002; 54(Suppl. 1): S131-55.
[http://dx.doi.org/10.1016/S0169-409X(02)00118-7] [PMID: 12460720]
[30]
Helgason T, Awad TS, Kristbergsson K, McClements DJ, Weiss J. Effect of surfactant surface coverage on formation of solid lipid nanoparticles (SLN). J Colloid Interface Sci 2009; 334(1): 75-81.
[http://dx.doi.org/10.1016/j.jcis.2009.03.012] [PMID: 19380149]
[31]
Chaudhary H, Rohilla A, Rathee P, Kumar V. Optimization and formulation design of carbopol loaded piroxicam gel using novel penetration enhancers. Int J Biol Macromol 2013; 55: 246-53.
[http://dx.doi.org/10.1016/j.ijbiomac.2013.01.015] [PMID: 23376559]
[32]
Shinde U, Pokharkar S, Modani S. Design and evaluation of microemulsion gel system of nadifloxacin. Indian J Pharm Sci 2012; 74(3): 237-47.
[http://dx.doi.org/10.4103/0250-474X.106066] [PMID: 23439454]
[33]
Singhvi G, Singh M. In-vitro drug release characterization models. Int J Pharm Stud Res 2011; 2: 77-84.
[34]
Singh AV, Ansari MHD, Rosenkranz D, et al. Artificial intelligence and machine learning in computational nanotoxicology: Unlocking and empowering nanomedicine. Adv Healthc Mater 2020; 9(17): e1901862.
[http://dx.doi.org/10.1002/adhm.201901862] [PMID: 32627972]
[35]
Singh AV, Rosenkranz D, Ansari MHD, et al. Artificial intelligence and machine learning empower advanced biomedical material design to toxicity prediction. Adv Intell Syst 2020; 2(12): 2000084.
[http://dx.doi.org/10.1002/aisy.202000084]
[36]
Singh AV, Dad Ansari MH, Dayan CB, et al. Multifunctional magnetic hairbot for untethered osteogenesis, ultrasound contrast imaging and drug delivery. Biomaterials 2019; 219: 119394.
[http://dx.doi.org/10.1016/j.biomaterials.2019.119394] [PMID: 31382208]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 11
ISSUE: 2
Year: 2021
Published on: 10 September, 2021
Page: [102 - 111]
Pages: 10
DOI: 10.2174/2468187311666210714124358
Price: $65

Article Metrics

PDF: 416
HTML: 3